Literature DB >> 25956193

A facile synthesis of versatile Cu2-xS nanoprobe for enhanced MRI and infrared thermal/photoacoustic multimodal imaging.

Juan Mou1, Chengbo Liu2, Pei Li3, Yu Chen1, Huixiong Xu3, Chenyang Wei1, Liang Song4, Jianlin Shi1, Hangrong Chen5.   

Abstract

A novel type of intelligent nanoprobe by using single component of Cu2-xS for multimodal imaging has been facilely and rapidly synthesized in scale via thermal decomposition followed by biomimetic phospholipid modification, which endows them with uniform and small nanoparticle size (ca.15 nm), well phosphate buffer saline (PBS) dispersity, high stability, and excellent biocompatibility. The as-synthesized Cu2-xS nanoprobes (Cu2-xS NPs) are capable of providing contrast enhancement for T1-weighted magnetic resonance imaging (MRI), as demonstrated by the both in vitro and in vivo imaging investigations for the first time. In addition, due to their strong near infrared (NIR) optical absorption, they can also serve as a candidate contrast agent for enhanced infrared thermal/photoacoustic imaging, to meet the shortfalls of MRI. Hence, complementary and potentially more comprehensive information can be acquired for the early detection and accurate diagnosis of cancer. Furthermore, negligible systematic side effects to the blood and tissue were observed in a relatively long period of 3 months. The distinctive multimodal imaging capability with excellent hemo/histocompatibility of the Cu2-xS NPs could open up a new molecular imaging possibility for detecting and diagnosing cancer or other diseases in the future.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Contrast agent; Cu(2−x)S nanoprobe; Infrared thermal imaging; Magnetic resonance imaging; Photoacoustic imaging

Mesh:

Substances:

Year:  2015        PMID: 25956193     DOI: 10.1016/j.biomaterials.2015.04.020

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Contrast-enhanced dual mode imaging: photoacoustic imaging plus more.

Authors:  Sungjo Park; Unsang Jung; Seunghyun Lee; Donghyun Lee; Chulhong Kim
Journal:  Biomed Eng Lett       Date:  2017-01-23

Review 2.  What is new in nanoparticle-based photoacoustic imaging?

Authors:  Jeanne E Lemaster; Jesse V Jokerst
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-04-01

Review 3.  Photoacoustic-Based Multimodal Nanoprobes: from Constructing to Biological Applications.

Authors:  Duyang Gao; Zhen Yuan
Journal:  Int J Biol Sci       Date:  2017-02-25       Impact factor: 6.580

4.  Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging.

Authors:  Lina A Basal; Yan Yan; Yimin Shen; E Mark Haacke; Mohammad Mehrmohammadi; Matthew J Allen
Journal:  ACS Omega       Date:  2017-03-06

Review 5.  Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging.

Authors:  Zhenghuan Zhao; Muyao Li; Jie Zeng; Linlin Huo; Kun Liu; Ruixue Wei; Kaiyuan Ni; Jinhao Gao
Journal:  Bioact Mater       Date:  2021-10-19

Review 6.  Exogenous Contrast Agents in Photoacoustic Imaging: An In Vivo Review for Tumor Imaging.

Authors:  Afifa Farooq; Shafiya Sabah; Salam Dhou; Nour Alsawaftah; Ghaleb Husseini
Journal:  Nanomaterials (Basel)       Date:  2022-01-25       Impact factor: 5.076

7.  Dual-modal photoacoustic and magnetic resonance tracking of tendon stem cells with PLGA/iron oxide microparticles in vitro.

Authors:  Man Lu; Xueqing Cheng; Jingzhen Jiang; TingTing Li; Zhenqi Zhang; Chialing Tsauo; Yin Liu; Zhigang Wang
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

8.  In Situ One-Pot Synthesis of MOF-Polydopamine Hybrid Nanogels with Enhanced Photothermal Effect for Targeted Cancer Therapy.

Authors:  Dongdong Wang; Huihui Wu; Jiajia Zhou; Pengping Xu; Changlai Wang; Ruohong Shi; Haibao Wang; Hui Wang; Zhen Guo; Qianwang Chen
Journal:  Adv Sci (Weinh)       Date:  2018-04-14       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.